Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ther Umsch. 2007 Nov;64(11):635-41.

[Antiviral treatment of influenza in humans].

[Article in German]

Author information

  • Medizinische Poliklinik, Universitätsspital Basel. nueschr@uhbs.ch

Abstract

Antiviral agents are the most effective treatment option for influenza. Two classes of drugs are available, the adamantanes and the neuraminidase inhibitors. Neuraminidase inhibitors were a major breakthrough in the treatment options for influenza and were licensed in the year 2000. They have an excellent safety profile and effectively reduce viral shedding, symptoms, duration of illness, secondary complications, hospitalizations and consumption of antibiotics. Patients have also shown a more rapid return to everyday activities. The therapeutic efficacy is highly dependent on the time between the onset of symptoms and the starting of therapy. Very early initiation is primordial to have a maximal effect. Neuraminidase inhibitors are also effective in primary and secondary prophylaxis during epidemic influenza. They are a key point in the pandemic preparedness. Resistance to neuraminidase inhibitors does occur but has not become an extensive problem so far.

PMID:
18581908
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk